Crystagen Dosage Guide, Benefits & Side Effects

Crystagen is not approved by the FDA (or most Western regulators) as a medication. In Russia, related Khavinson bioregulator products have regulatory approval and clinical use history, but that does not extend to FDA/EU market authorization elsewhere. Outside Russia, it is generally sold either labeled 'not a medicinal product' / for research use only, or as an unregulated dietary supplement depending on the jurisdiction and vendor. Buyers should check their local laws, since the legal status of importing and using unapproved peptide products varies by country.

Sellers generally recommend storing unopened Crystagen vials or drops refrigerated (roughly 2-8°C / 36-46°F), protected from light and freezing. Reconstituted injectable solution is typically advised to be kept refrigerated and used within about 2-4 weeks. Sublingual liquid products list a printed expiration date on the packaging and should be used before that date and stored per the manufacturer's label instructions.

Crystagen is part of a broader family of Khavinson tissue-specific bioregulator peptides (e.g., Thymalin/thymus, Vladonix/immune, Epithalon/pineal), and some vendor and clinical protocols describe combining it with other bioregulators, such as pineal gland peptides, as part of broader anti-aging or immune-support regimens. There is limited independent research specifically evaluating peptide combinations, so claims about enhanced benefits from stacking are largely anecdotal or based on manufacturer literature rather than robust clinical evidence.

Crystagen and related Khavinson-group peptides have been studied mainly in Russian-language research and some published animal and in-vitro work, along with observational human studies from the same research group (for example, reports of improved immune parameter normalization in elderly cohorts). This body of evidence is smaller, less independently replicated, and less rigorously controlled than what would be required for drug approval in the US or EU. As with any research peptide, product sold for laboratory or research purposes is explicitly not intended for human use, and existing evidence should be considered preliminary rather than conclusive.